{"id":1068173,"date":"2022-04-27T02:14:15","date_gmt":"2022-04-27T06:14:15","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/collegium-to-host-conference-call-to-discuss-first-quarter-2022-financial-results\/"},"modified":"2024-08-18T11:43:53","modified_gmt":"2024-08-18T15:43:53","slug":"collegium-to-host-conference-call-to-discuss-first-quarter-2022-financial-results","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/collegium-to-host-conference-call-to-discuss-first-quarter-2022-financial-results.php","title":{"rendered":"Collegium to Host Conference Call to Discuss First Quarter 2022 Financial Results"},"content":{"rendered":"<p><![CDATA[STOUGHTON, Mass., April  26, 2022  (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company, today announced that the Company will host a conference call and live audio webcast on Tuesday, May 10, 2022 at 4:30 p.m. ET. The Company will discuss its first quarter 2022 financial results and provide a corporate update.]]><\/p>\n<p>Excerpt from:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/04\/26\/2429584\/0\/en\/Collegium-to-Host-Conference-Call-to-Discuss-First-Quarter-2022-Financial-Results.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Collegium to Host Conference Call to Discuss First Quarter 2022 Financial Results\">Collegium to Host Conference Call to Discuss First Quarter 2022 Financial Results<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Excerpt from: Collegium to Host Conference Call to Discuss First Quarter 2022 Financial Results <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/collegium-to-host-conference-call-to-discuss-first-quarter-2022-financial-results.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068173","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068173"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068173"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068173\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068173"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068173"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068173"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}